Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 57

1.

Altered thymic CD4+ T-cell recovery after allogeneic hematopoietic stem cell transplantation is critical for nocardiosis.

Roussel X, Daguindau E, Berceanu A, Desbrosses Y, Saas P, Ferrand C, Seilles E, Pouthier F, Deconinck E, Larosa F.

Curr Res Transl Med. 2019 Jun 1. pii: S2452-3186(19)30019-4. doi: 10.1016/j.retram.2019.05.001. [Epub ahead of print]

PMID:
31164285
2.

CML Hematopoietic Stem Cells Expressing IL1RAP Can Be Targeted by Chimeric Antigen Receptor-Engineered T Cells.

Warda W, Larosa F, Neto Da Rocha M, Trad R, Deconinck E, Fajloun Z, Faure C, Caillot D, Moldovan M, Valmary-Degano S, Biichle S, Daguindau E, Garnache-Ottou F, Tabruyn S, Adotevi O, Deschamps M, Ferrand C.

Cancer Res. 2019 Feb 1;79(3):663-675. doi: 10.1158/0008-5472.CAN-18-1078. Epub 2018 Dec 4.

PMID:
30514753
3.

Association between Hippocampal Shape, Neuroinflammation, and Cognitive Decline in Alzheimer's Disease.

Cabinio M, Saresella M, Piancone F, LaRosa F, Marventano I, Guerini FR, Nemni R, Baglio F, Clerici M.

J Alzheimers Dis. 2018;66(3):1131-1144. doi: 10.3233/JAD-180250.

PMID:
30400090
4.

Brushed nasal epithelial cells are a surrogate for bronchial epithelial CFTR studies.

Brewington JJ, Filbrandt ET, LaRosa FJ 3rd, Moncivaiz JD, Ostmann AJ, Strecker LM, Clancy JP.

JCI Insight. 2018 Jul 12;3(13). pii: 99385. doi: 10.1172/jci.insight.99385.

5.

Generation of Human Nasal Epithelial Cell Spheroids for Individualized Cystic Fibrosis Transmembrane Conductance Regulator Study.

Brewington JJ, Filbrandt ET, LaRosa FJ 3rd, Moncivaiz JD, Ostmann AJ, Strecker LM, Clancy JP.

J Vis Exp. 2018 Apr 11;(134). doi: 10.3791/57492.

PMID:
29708545
6.

Cytotect®CP as salvage therapy in patients with CMV infection following allogeneic hematopoietic cell transplantation: a multicenter retrospective study.

Alsuliman T, Kitel C, Dulery R, Guillaume T, Larosa F, Cornillon J, Labussière-Wallet H, Médiavilla C, Belaiche S, Delage J, Alain S, Yakoub-Agha I.

Bone Marrow Transplant. 2018 Oct;53(10):1328-1335. doi: 10.1038/s41409-018-0166-9. Epub 2018 Apr 13.

PMID:
29654288
7.

SALL4 oncogene is an immunogenic antigen presented in various HLA-DR contexts.

Kroemer M, Spehner L, Mercier-Letondal P, Boullerot L, Kim S, Jary M, Galaine J, Picard E, Ferrand C, Nguyen T, Larosa F, Adotévi O, Godet Y, Borg C.

Oncoimmunology. 2018 Jan 17;7(4):e1412030. doi: 10.1080/2162402X.2017.1412030. eCollection 2018.

8.

Clinical Assessment of a Nocardia PCR-Based Assay for Diagnosis of Nocardiosis.

Rouzaud C, Rodriguez-Nava V, Catherinot E, Méchaï F, Bergeron E, Farfour E, Scemla A, Poirée S, Delavaud C, Mathieu D, Durupt S, Larosa F, Lengelé JP, Christophe JL, Suarez F, Lortholary O, Lebeaux D.

J Clin Microbiol. 2018 May 25;56(6). pii: e00002-18. doi: 10.1128/JCM.00002-18. Print 2018 Jun.

9.

Immunological and Clinical Effect of Diet Modulation of the Gut Microbiome in Multiple Sclerosis Patients: A Pilot Study.

Saresella M, Mendozzi L, Rossi V, Mazzali F, Piancone F, LaRosa F, Marventano I, Caputo D, Felis GE, Clerici M.

Front Immunol. 2017 Oct 25;8:1391. doi: 10.3389/fimmu.2017.01391. eCollection 2017.

10.

Detection of CFTR function and modulation in primary human nasal cell spheroids.

Brewington JJ, Filbrandt ET, LaRosa FJ 3rd, Ostmann AJ, Strecker LM, Szczesniak RD, Clancy JP.

J Cyst Fibros. 2018 Jan;17(1):26-33. doi: 10.1016/j.jcf.2017.06.010. Epub 2017 Jul 13.

11.

Impact of body-surface area on patients' outcome in younger adults with acute myeloid leukemia.

Cahu X, Carré M, Recher C, Pigneux A, Hunault-Berger M, Vey N, Chevallier P, Delaunay J, Gyan E, Lioure B, Bonmati C, Himberlin C, Hicheri Y, Guillerm G, Didier B, Larosa F, Ojeda-Uribe M, Bernard M, Bene MC, Ifrah N, Cahn JY.

Eur J Haematol. 2017 May;98(5):443-449. doi: 10.1111/ejh.12850. Epub 2017 Mar 1.

PMID:
28122150
12.

Exposure to hypomethylating agent, 5-azacytidine, may improve iCasp9 suicide gene therapy for treating GvHD in allografts.

Bôle-Richard E, Gamonet C, Certoux JM, Idirene I, Larosa F, Deconinck E, Mosseley AM, Tiberghien P, Borg C, Ferrand C, Deschamps M.

Gene Ther. 2016 Aug;23(8-9):664-72. doi: 10.1038/gt.2016.39. Epub 2016 May 12.

PMID:
27111151
13.

Combining Aspergillus mitochondrial and ribosomal QPCR, in addition to galactomannan assay, for early diagnosis of invasive aspergillosis in hematology patients.

Bellanger AP, Millon L, Berceanu A, Grenouillet F, Grenouillet FE, Larosa F, Deconinck E.

Med Mycol. 2015 Sep;53(7):760-4. doi: 10.1093/mmy/myv051. Epub 2015 Jul 10.

PMID:
26162471
14.

The p16(INK4A)/pRb pathway and telomerase activity define a subgroup of Ph+ adult Acute Lymphoblastic Leukemia associated with inferior outcome.

Chien WW, Catallo R, Chebel A, Baranger L, Thomas X, Béné MC, Gerland LM, Schmidt A, Beldjord K, Klein N, Escoffre-Barbe M, Leguay T, Huguet F, Larosa F, Hayette S, Plesa A, Ifrah N, Dombret H, Salles G, Chassevent A, Ffrench M.

Leuk Res. 2015 Apr;39(4):453-61. doi: 10.1016/j.leukres.2015.01.008. Epub 2015 Jan 25.

PMID:
25675863
15.

[Mucositis after allogeneic stem cell transplantation: Risk factors, clinical consequences and prophylaxis].

Bourdelin M, Daguindau E, Larosa F, Legrand F, Nerich V, Deconinck E, Limat S.

Pathol Biol (Paris). 2015 Apr;63(2):106-10. doi: 10.1016/j.patbio.2014.11.001. Epub 2014 Dec 30. French.

PMID:
25555496
16.

Erratum to: New CD20 alternative splice variants: molecular identification and differential expression within hematological B cell malignancies.

Gamonet C, Bole-Richard E, Delherme A, Aubin F, Toussirot E, Garnache-Ottou F, Godet Y, Ysebaert L, Tournilhac O, Dartigeas C, Larosa F, Deconinck E, Saas P, Borg C, Deschamps M, Ferrand C.

Exp Hematol Oncol. 2016 Apr 14;5:10. doi: 10.1186/s40164-016-0038-1. eCollection 2015.

17.

New CD20 alternative splice variants: molecular identification and differential expression within hematological B cell malignancies.

Gamonet C, Bole-Richard E, Delherme A, Aubin F, Toussirot E, Garnache-Ottou F, Godet Y, Ysebaert L, Tournilhac O, Caroline D, Larosa F, Deconinck E, Saas P, Borg C, Deschamps M, Ferrand C.

Exp Hematol Oncol. 2016 Mar 1;5:7. doi: 10.1186/s40164-016-0036-3. eCollection 2015. Erratum in: Exp Hematol Oncol. 2015;5:10.

18.

Posaconazole prophylaxis in neutropenic patients with hematological malignancies: limits in clinical practice.

Bourdelin M, Grenouillet F, Daguindau E, Muret P, Desbrosses Y, Dubut J, Deconinck E, Limat S, Larosa F.

Med Mycol. 2014 Oct;52(7):728-35. doi: 10.1093/mmy/myu042. Epub 2014 Jul 10.

PMID:
25012993
19.

Diagnosis and management of nocardiosis after bone marrow stem cell transplantation in adults: lack of lymphocyte recovery as a major contributing factor.

Mansi L, Daguindau E, Saas P, Pouthier F, Ferrand C, Dormoy A, Patry I, Garnache F, Rohrlich PS, Deconinck E, Larosa F.

Pathol Biol (Paris). 2014 Jun;62(3):156-61. doi: 10.1016/j.patbio.2014.04.001. Epub 2014 May 27.

PMID:
24875455
20.

Evaluation of invasive aspergillosis risk of immunocompromised patients alternatively hospitalized in hematology intensive care unit and at home.

Rocchi S, Reboux G, Larosa F, Scherer E, Daguindeau E, Berceanu A, Deconinck E, Millon L, Bellanger AP.

Indoor Air. 2014 Dec;24(6):652-61. doi: 10.1111/ina.12108. Epub 2014 Apr 4.

PMID:
24621176
21.

A successful renal transplantation for renal failure after dasatinib-induced thrombotic thrombocytopenic purpura in a patient with imatinib-resistant chronic myelogenous leukaemia on nilotinib.

Martino S, Daguindau E, Ferrand C, Bamoulid J, Hayette S, Nicolini FE, Capellier G, Deconinck E, Larosa F.

Leuk Res Rep. 2013 Mar 19;2(1):29-31. doi: 10.1016/j.lrr.2013.02.003. eCollection 2013.

22.

Non-Hodgkin's lymphoma: unexpected cause of shoulder pain. A systematic review of the literature.

Caporale MF, Gambino GF, Larosa FS, Del Buono A, Di Segni F.

Muscles Ligaments Tendons J. 2013 Aug 11;3(3):236-9. eCollection 2013 Jul.

23.

Quantitative polymerase chain reaction detection of circulating DNA in serum for early diagnosis of mucormycosis in immunocompromised patients.

Millon L, Larosa F, Lepiller Q, Legrand F, Rocchi S, Daguindau E, Scherer E, Bellanger AP, Leroy J, Grenouillet F.

Clin Infect Dis. 2013 May;56(10):e95-101. doi: 10.1093/cid/cit094. Epub 2013 Feb 18.

PMID:
23420816
24.

Early matched sibling hematopoietic cell transplantation for adult AML in first remission using an age-adapted strategy: long-term results of a prospective GOELAMS study.

Lioure B, Béné MC, Pigneux A, Huynh A, Chevallier P, Fegueux N, Blaise D, Witz B, Delain M, Cornillon J, Luquet I, Blanchet O, Cornillet-Lefebvre P, Carré M, Hunault M, Larosa F, Lamy T, Randriamalala E, Ojeda-Uribe M, Berthou C, Fornecker L, Harousseau JL, Bouscary D, Ifrah N, Cahn JY; GOELAMS.

Blood. 2012 Mar 22;119(12):2943-8. doi: 10.1182/blood-2011-05-352989. Epub 2012 Feb 9.

25.

Systematic donor blood qualification by flow cytometry would have been able to avoid CLL-type MBL transmission after unrelated hematopoietic stem cell transplantation.

Ferrand C, Garnache-Ottou F, Collonge-Rame MA, Larosa F, Blanc M, Behar C, Giannoli C, Garnier F, Tiberghien P, Deconinck E, Rohrlich PS.

Eur J Haematol. 2012 Mar;88(3):269-72. doi: 10.1111/j.1600-0609.2011.01741.x. Epub 2012 Jan 10.

PMID:
22168404
26.

CD304 is preferentially expressed on a subset of B-lineage acute lymphoblastic leukemia and represents a novel marker for minimal residual disease detection by flow cytometry.

Solly F, Angelot F, Garand R, Ferrand C, Seillès E, Schillinger F, Decobecq A, Billot M, Larosa F, Plouvier E, Deconinck E, Legrand F, Saas P, Rohrlich PS, Garnache-Ottou F.

Cytometry A. 2012 Jan;81(1):17-24. doi: 10.1002/cyto.a.21162. Epub 2011 Nov 3.

27.

Successful mobilization and engraftment of PBSCs derived from donor cord blood cells after a previous allogeneic RIC single unrelated cord blood transplantation.

Larosa F, Deconinck E, Helias P, Fontan J, Heczko M, Brion A, Ledu K, Delaby P, Vuiller J, Ferrand C, Saas P, Pouthier F, Dormoy A, Chabod J, Malugani C, Rohrlich PS, Legrand F.

Blood. 2011 Jul 14;118(2):476-8. doi: 10.1182/blood-2011-03-343640. No abstract available.

28.

Intrathecal liposomal cytarabine (lipoCIT) administration in patients with leukemic or lymphomatous meningitis: efficacy and long-term safety in a single institution.

Brion A, Legrand F, Larosa F, Schillinger F, Garnache-Ottou F, Helias P, Fontan J, Heczko M, Delaby P, Daguindau E, Vuillier J, Chauchet A, Deconinck E.

Invest New Drugs. 2012 Aug;30(4):1697-702. doi: 10.1007/s10637-011-9632-6. Epub 2011 Jan 13.

PMID:
21229289
29.

A randomized study of pegylated liposomal doxorubicin versus continuous-infusion doxorubicin in elderly patients with acute lymphoblastic leukemia: the GRAALL-SA1 study.

Hunault-Berger M, Leguay T, Thomas X, Legrand O, Huguet F, Bonmati C, Escoffre-Barbe M, Legros L, Turlure P, Chevallier P, Larosa F, Garban F, Reman O, Rousselot P, Dhédin N, Delannoy A, Lafage-Pochitaloff M, Béné MC, Ifrah N, Dombret H; Group for Research on Adult Acute Lymphoblastic Leukemia (GRAALL).

Haematologica. 2011 Feb;96(2):245-52. doi: 10.3324/haematol.2010.027862. Epub 2010 Oct 22.

30.

Diagnosis and treatment of digestive cryptosporidiosis in allogeneic haematopoietic stem cell transplant recipients: a prospective single centre study.

Legrand F, Grenouillet F, Larosa F, Dalle F, Saas P, Millon L, Deconinck E, Rohrlich PS.

Bone Marrow Transplant. 2011 Jun;46(6):858-62. doi: 10.1038/bmt.2010.200. Epub 2010 Aug 23.

PMID:
20729925
31.

Persistence of lymphocyte function perturbations after granulocyte-colony-stimulating factor mobilization and cytapheresis in normal peripheral blood stem cell donors.

Marmier-Savet C, Larosa F, Legrand F, Witz B, Michallet M, Ranta D, Louvat P, Puyraveau M, Raus N, Tavernier M, Mathieu-Nafissi S, Hequet O, Pouthier F, Deconinck E, Tiberghien P, Robinet E.

Transfusion. 2010 Dec;50(12):2676-85. doi: 10.1111/j.1537-2995.2010.02781.x. Erratum in: Transfusion. 2011 May;51(5):1126. Raus, Nicole [added]; Tavernier, Maribel [added]; Mathieu-Nafissi, Suzanne [added]; Hequet, Olivier [added].

PMID:
20663114
32.

Early immune reconstitution and efficient graft vs tumor effect after unrelated partially matched double cord blood transplantation in refractory 8p11 syndrome.

Larosa F, Maddens S, Legrand F, Pouthier F, Ferrand C, Saas P, Hayette S, Chabod J, Tiberghien P, Rohrlich PS, Deconinck E.

Bone Marrow Transplant. 2011 Apr;46(4):622-4. doi: 10.1038/bmt.2010.171. Epub 2010 Jul 26. No abstract available.

PMID:
20661237
33.

False-positive Aspergillus real-time PCR assay due to a nutritional supplement in a bone marrow transplant recipient with GVH disease.

Millon L, Grenouillet F, Crouzet J, Larosa F, Loewert S, Bellanger AP, Deconinck E, Legrand F.

Med Mycol. 2010 Jun;48(4):661-4. doi: 10.3109/13693780903451836.

PMID:
20392146
34.

G-CSF-induced aneuploidy does not affect CD34+ cells and does not require cell division.

Marmier-Savet C, Larosa F, Legrand F, Witz B, Michallet M, Ranta D, Louvat P, Puyraveau M, Raus N, Tavernier M, Mathieu-Nafissi S, Hequet O, Pallandre JR, Vitte F, Collonge-Rame MA, Pouthier F, Bresson JL, Deconinck E, Tiberghien P, Robinet E.

Blood. 2010 Jan 28;115(4):910-1. doi: 10.1182/blood-2009-10-250837. No abstract available.

35.

Allogeneic hematopoietic stem cell transplantation allows long-term complete remission and curability in high-risk Waldenström’s macroglobulinemia. Results of a retrospective analysis of the Société Française de Greffe de Moelle et de Thérapie Cellulaire.

Garnier A, Robin M, Larosa F, Golmard JL, Le Gouill S, Coiteux V, Tabrizi R, Bulabois CE, Cacheux V, Kuentz M, Dreyfus B, Dreger P, Rio B, Moles-Moreau MP, Bilger K, Bay JO, Leblond V, Blaise D, Tournilhac O, Dhédin N.

Haematologica. 2010 Jun;95(6):950-5. doi: 10.3324/haematol.2009.017814. Epub 2010 Jan 15.

36.

Low nonrelapse mortality and prolonged long-term survival after reduced-intensity allogeneic stem cell transplantation for relapsed or refractory diffuse large B cell lymphoma: report of the Société Française de Greffe de Moelle et de Thérapie Cellulaire.

Sirvent A, Dhedin N, Michallet M, Mounier N, Faucher C, Yakoub-Agha I, Mohty M, Robin M, Tabrizi R, Clement L, Bilger K, Larosa F, Contentin N, Huyn A, François S, Bulabois CE, Ceballos P, Bourrhis JH, Buzyn A, Cornillon J, Guillerm G, de Revel T, Bay JO, Guilhot F, Milpied N.

Biol Blood Marrow Transplant. 2010 Jan;16(1):78-85. doi: 10.1016/j.bbmt.2009.09.002. Epub 2009 Sep 8.

37.

Pharmacokinetic modelling and development of Bayesian estimators for therapeutic drug monitoring of mycophenolate mofetil in reduced-intensity haematopoietic stem cell transplantation.

Saint-Marcoux F, Royer B, Debord J, Larosa F, Legrand F, Deconinck E, Kantelip JP, Marquet P.

Clin Pharmacokinet. 2009;48(10):667-75. doi: 10.2165/11317140-000000000-00000.

38.

Pharmacokinetics of mycophenolic acid administered 3 times daily after hematopoietic stem cell transplantation with reduced-intensity regimen.

Royer B, Larosa F, Legrand F, Gerritsen-van Schieveen P, Bérard M, Kantelip JP, Deconinck E.

Biol Blood Marrow Transplant. 2009 Sep;15(9):1134-9. doi: 10.1016/j.bbmt.2009.04.011. Epub 2009 Jun 18.

39.

Infliximab treatment for steroid-refractory acute graft-versus-host disease after orthotopic liver transplantation: a case report.

Piton G, Larosa F, Minello A, Becker MC, Mantion G, Aubin F, Deconinck E, Hillon P, Di Martino V.

Liver Transpl. 2009 Jul;15(7):682-5. doi: 10.1002/lt.21793.

40.

Bone scintigraphy pattern of joint chronic graft-versus-host disease after allogeneic bone marrow transplantation.

Zsigmond R, Ungureanu C, Blagosklonov O, Biancheri I, Angoué O, Runge M, Wendling D, Larosa F, Paycha F, Boulahdour H.

Clin Nucl Med. 2009 Jan;34(1):20-3. doi: 10.1097/RLU.0b013e31818f4355. No abstract available.

PMID:
19092377
41.

Scedosporium prolificans: an emerging pathogen in France?

Grenouillet F, Botterel F, Crouzet J, Larosa F, Hicheri Y, Forel JM, Helias P, Ranque S, Delhaes L.

Med Mycol. 2009 Jun;47(4):343-50. doi: 10.1080/13693780802454761. Epub 2008 Dec 12. Review.

PMID:
19085456
42.

A phase II trial of high-dose imatinib mesylate for relapsed or refractory c-kit positive and Bcr-Abl negative acute myeloid leukaemia: the AFR-15 trial.

Chevallier P, Hunault-Berger M, Larosa F, Dauriac C, Garand R, Harousseau JL.

Leuk Res. 2009 Aug;33(8):1124-6. doi: 10.1016/j.leukres.2008.09.030. Epub 2008 Nov 5.

PMID:
18990444
43.

Barometric changes in patients with intracranial lesions: can they dive and fly?

Perin A, Larosa F, Longatti P.

Surg Neurol. 2009 Mar;71(3):368-71, discussion 371. doi: 10.1016/j.surneu.2007.08.033. Epub 2008 Jan 22. Review.

PMID:
18207519
44.

Thalidomide versus placebo in myeloid metaplasia with myelofibrosis: a prospective, randomized, double-blind, multicenter study.

Abgrall JF, Guibaud I, Bastie JN, Flesch M, Rossi JF, Lacotte-Thierry L, Boyer F, Casassus P, Slama B, Berthou C, Rodon P, Leporrier M, Villemagne B, Himberlin C, Ghomari K, Larosa F, Rollot F, Dugay J, Allard C, Maigre M, Isnard F, Zerbib R, Cauvin JM; Groupe Ouest-Est Leucémies et Maladies du Sang (GOELAMS).

Haematologica. 2006 Aug;91(8):1027-32.

45.

Peripheral T-cell expansion and low infection rate after reduced-intensity conditioning and allogeneic blood stem cell transplantation.

Larosa F, Marmier C, Robinet E, Ferrand C, Saas P, Deconinck E, Bulabois CE, Rohrlich PS, Ledu K, Helias P, Tiberghien P, Cahn JY.

Bone Marrow Transplant. 2005 May;35(9):859-68.

PMID:
15765116
46.

Polyvisceral arteritis in chronic graft-versus-host disease: antiphospholipid-negative thrombotic syndrome mimicking polyarteritis nodosa.

Ysebaert L, Deconinck E, Larosa F, Caillot D, Tiberghien P, Casasnovas RO, Cahn JY.

Bone Marrow Transplant. 2002 May;29(10):873-4.

47.

Adoptive transfer of ex vivo activated memory T-cells with or without cyclophosphamide for advanced metastatic melanoma: results in 36 patients.

Gold JE, Ross SD, Krellenstein DJ, LaRosa F, Malamud SC, Osband ME.

Eur J Cancer. 1995;31A(5):698-708.

PMID:
7640041
48.
49.

Altered cytokine activity in adjuvant inhibition of autoimmune diabetes.

Shehadeh NN, LaRosa F, Lafferty KJ.

J Autoimmun. 1993 Jun;6(3):291-300.

PMID:
8397713
50.

Supplemental Content

Loading ...
Support Center